View Older Stories View More Recent Stories
-
NetApp (NTAP) PT Raised to $63 at BMO Capital
-
Interpublic Group (IPG) PT Raised to $27 at BMO Capital; Strong Rebound
-
Criteo S.A. (CRTO) PT Raised to $32 at BMO Capital; ITP's Impact Less Severe
-
Dollar cools despite rising bond yields, hits 15-month low vs. yen
-
Global stocks climb, shrugging off inflation data; dollar falls
-
Piper Jaffray Expands Industrials Investment Banking Group with Hiring of Doug Lawson
-
Ra Pharmaceuticals (RARX) Prices 8.4M Common Stock Offering at $6/Share
-
Ra Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
BMO Capital Upgrades Patterson-UTI Energy (PTEN) to Outperform
-
BMO Capital Downgrades Tetraphase Pharmaceuticals (TTPH) to Market Perform
-
Nutrien to present at the BMO Capital Markets 27th Global Metals and Mining Conference
-
Ra Pharmaceuticals (RARX) to Offer $50M of Common Stock
-
Ra Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
BioXcel Therapeutics Files Registration Statement for Proposed Initial Public Offering
-
BMO Financial Group Releases Supplementary Financial Information Reflecting Changes in Presentation Related to the Adoption of IFRS 9
-
BMO Financial Group Releases Supplementary Financial Information Reflecting Changes in Presentation Related to the Adoption of IFRS 9
-
Hardinge (HDNG) Agrees to be Acquired by Privet for $18.50/Share
-
Potlatch (PCH) PT Raised to $49 at BMO Capital
-
Genpact Ltd. (G) PT Raised to $35 at BMO Capital
-
Hardinge Inc. to be Acquired by Privet Fund Management LLC for $18.50 per Share in Cash
-
BioXcel Therapeutics (BTAI) Files $69M IPO
-
Twitter, Inc. (TWTR) PT Raised to $28 at BMO Capital Following 4Q
-
Patterson-UTI Energy (PTEN) PT Lowered to $24 at BMO Capital
-
Oaktree Specialty Lending Corp (OCSL) PT Lowered to $4 at BMO Capital
-
Nielsen Holdings (NLSN) PT Lowered to $38 at BMO Capital
-
Mednax (MD) PT Raised to $58 at BMO Capital
-
Moody's Corp (MCO) PT Raised to $161 at BMO Capital
-
BMO Capital Upgrades Dunkin' Brands (DNKN) to Outperform
-
Brookfield Infrastructure Partners (BIP) PT Lowered to $47 at BMO Capital, Says Underlying Fundamentals Remain Solid
-
Broadcom (AVGO) Says it Signed Binding Financing Commitments to Fund Cash Component of Qualcomm (QCOM) Acquisition
-
Broadcom and Financing Sources Sign Binding Financing Commitments to Fund Cash Component of Qualcomm Acquisition
-
Autoliv, Inc. (ALV) PT Raised to $175 at BMO Capital Following Meeting With Management, Says Still More Value to Be Unlocked
-
21st Century Fox (FOXA) PT Raised to $37 at BMO Capital
-
Twitter, Inc. (TWTR) PT Raised to $28 at BMO Capital, 'Solid Steps Down Road to Recovery'
-
Viacom (VIAB) PT Raised to $34 at BMO Capital, 'Recovery Trajectory Looking Better Than Expected'
-
IAC/InterActiveCorp (IAC) PT Raised to $193 at BMO Capital
-
Sally Beauty Holdings (SBH) PT Raised to $18 at BMO Capital
-
Coty Inc. (COTY) PT Raised to $24 at BMO Capital
-
SAGE Therapeutics (SAGE) Prices 3.5M Shares at $164
-
DXC Technology (DXC) PT Raised to $117 at BMO Capital
-
BMO Capital Upgrades BB&T Capital (BBT) to Outperform
-
BMO Capital Upgrades Comerica (CMA) to Outperform
-
BMO Capital Upgrades TCF Financial (TCF) to Outperform
-
NVIDIA (NVDA) PT Raised to $225 at BMO Capital
-
Sage Therapeutics Prices Public Offering of Common Stock
-
Senior Housing Properties Trust Prices $500 Million of 4.750% Senior Notes Due 2028
-
Bank of Montreal to Redeem $900,000,000 6.17% Series F Medium-Term Notes First Tranche
-
Bank of Montreal to Redeem $900,000,000 6.17% Series F Medium-Term Notes First Tranche
-
Form 13F-NT BMO CAPITAL MARKETS CORP For: Dec 31
-
Alnylam Pharmaceuticals (ALNY) PT Lowered to $160 at BMO Capital

